JSM 2012 Home

JSM 2012 Online Program

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

Online Program Home

Activity Details

223 * ! Mon, 7/30/2012, 2:00 PM - 3:50 PM CC-Room 25B
Neurodegenerative Diseases in Our Aging Population: Novel Approaches to Clinical Trial Design — Topic Contributed Papers
Biopharmaceutical Section
Organizer(s): Pilar Lim, Janssen Pharmaceuticals R&D
Chair(s): Allan Sampson, University of Pittsburgh
2:05 PM Assessing missing data impact in a clinical trial prior to unblinding using a parametric bootstrap approach Jianing Di, Janssen Alzheimer Immunotherapy R&D, LLC
2:25 PM Lessons Learned from a Delayed Start Trial Review Experience Tristan Massie, FDA
2:45 PM Design Considerations for Secondary Prevention Trials in Alzheimer's Disease Ronald Thomas, ADCS Data Core
3:05 PM A Doubly Randomized Delayed-Start Design for Clinical Trials in Early Intervention of Neurodegenerative Diseases
3:25 PM Discussant: Michael Krams, Janssen Pharmaceuticals R&D
3:45 PM Floor Discussion

2012 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.